Brief: Gensight Biologics H1 Net Loss Narrows To EUR 14.1 Mln

Gensight Biologics SA

30/07/2020 06:38

July 30 (Reuters) - GENSIGHT BIOLOGICS SA  SIGHT.PA :
    * H1 NET LOSS -14.1 MILLION EUR VERSUS -17.3 MILLION EUR
LOSS YEAR
AGO
    * NET CASH FLOWS FROM OPERATING ACTIVITIES IN FIRST HALVES
OF 2020
AND 2019 WERE EUR (6.7) MILLION AND EUR (19.5) MILLION,
RESPECTIVELY.
    * H1 OPERATING INCOME EUR 3.3  MILLION VERSUS EUR 2.5
MILLION YEAR
AGO
    * H1 OPERATING LOSS EUR 13.6 MILLION VERSUS LOSS OF EUR 17.2
MILLION YEAR AGO
    * H1 NET LOSS EUR 14.1 MILLION VERSUS LOSS OF EUR 17.3
MILLION
YEAR AGO

Source text for Eikon:  ID:nBw1DJqSka 
Further company coverage:  SIGHT.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))